These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6547466)
1. [A case report of neoplastic angioendotheliosis which responded to a combination chemotherapy (CHOP)]. Shiozaki H; Hoshino S; Oshimi K; Mizoguchi H; Tsuzuki C; Hidano A; Mori S Nihon Naika Gakkai Zasshi; 1984 Mar; 73(3):374-8. PubMed ID: 6547466 [No Abstract] [Full Text] [Related]
2. Neoplastic angioendotheliosis with B lymphocyte markers on neoplastic cells: a case report. Mori S; Takanashi M; Motoji T; Shiozaki H; Oshimi K; Mizoguchi H Jpn J Cancer Res; 1985 Mar; 76(3):208-12. PubMed ID: 3922839 [TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy for the treatment of angiosarcoma]. Masuzawa M Gan To Kagaku Ryoho; 1993 Aug; 20(10):1314-9. PubMed ID: 8346929 [TBL] [Abstract][Full Text] [Related]
11. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: report of two cases with no evidence of systemic disease. Szepesi Á; Csomor J; Rajnai H; Erős N; Wikonkál N; Kárpáti S; Matolcsy A; Marschalkó M Eur J Dermatol; 2012; 22(5):690-1. PubMed ID: 22940730 [No Abstract] [Full Text] [Related]
12. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [TBL] [Abstract][Full Text] [Related]
13. Leukaemic presentation of angioimmunoblastic T-cell lymphoma. Lin KW; Lee YS; Phipps C Br J Haematol; 2014 Sep; 166(6):808. PubMed ID: 24974735 [No Abstract] [Full Text] [Related]
14. [Cutaneous B-cell lymphoma with aggressive clinical presentation: apropos of a case]. Grau E; Real E; Perella M; Escandon J; Pastor E; Gómez A Sangre (Barc); 1997 Jun; 42(3):231-3. PubMed ID: 9381268 [TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase II Study. Miller TP; Jones SE; Rainey JM Cancer Treat Rep; 1983; 67(7-8):739-40. PubMed ID: 6688200 [No Abstract] [Full Text] [Related]
16. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy. Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171 [TBL] [Abstract][Full Text] [Related]
17. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model. Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256 [TBL] [Abstract][Full Text] [Related]
18. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764 [TBL] [Abstract][Full Text] [Related]
19. [Combined CHOP and radiotherapy in non-Hodgkin's lymphoma of unfavorable histology]. Tominaga S; Kondo M Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2249-56. PubMed ID: 3819551 [No Abstract] [Full Text] [Related]
20. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]